|
 |
Attorney General Mike DeWine
Naloxone Rebate
Agreement Extended
(COLUMBUS, Ohio)— Ohio Attorney General Mike DeWine announced today
that a rebate agreement that has saved agencies thousands of dollars on
the cost of the opioid reversal medication naloxone is being extended
for one year.
The renewed agreement with Amphastar Pharmaceuticals, Inc. will allow
non-federal public entities in Ohio to continue receiving a $6 rebate
for each Amphastar naloxone syringe purchased until March 2, 2017.
"I'm pleased to secure these valuable rebates for another year," said
Attorney General DeWine. "Naloxone saves lives, and I applaud the law
enforcement agencies, fire departments, and others who are using it to
help combat the opiate epidemic."
So far, nearly 60 Ohio agencies have applied for more than $151,000 in
rebates to offset the cost of the life-saving drug. When given to
a person overdosing on heroin or a prescription opioid, naloxone can
limit or stop the overdose by reversing the effects of the opioid on
the brain.
According to the Ohio Department of Public Safety, Division of EMS,
current data available shows naloxone was administered more than 16,000
times in Ohio in 2015.
The agreement initially went into effect in March 2015 after Attorney
General DeWineapproached the company following a dramatic increase in
the price of Amphastar naloxone.
If Amphastar raises its wholesale price of naloxone during the term of
the agreement, the company has also agreed to increase the rebate
amount.
Non-federal, Ohio government agencies are eligible to receive rebate
payments. This includes, but is not limited to, state agencies,
law enforcement agencies, fire departments, emergency medical services,
county health departments, Project DAWN community programs, and county
or local government agencies.
For information on how to apply for the rebates visit
www.OhioAttorneyGeneral.gov/NaloxoneRebate.
|
|
|
|
